QHA

X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device

产品代码
QHA
器械名称
X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 892.1600
FDA 专业组
Radiology
上市路径
需提交 510(k) 上市前通告
该代码近三年的 510(k)
7 件

FDA 分类定义

X-ray angiographic imaging based coronary vascular simulation software device is a prescription device that provides an image analysis tool to assess blood flow in the coronary vascular system using X-ray angiographic imaging data. X-ray angiographic imaging based coronary vascular simulation software device solves algorithms and yields simulation-based metrics for certain cardiology applications. X-ray angiographic imaging based coronary vascular simulation software device cannot be used alone for clinical decision making and clinical management, and is a tool intended to generate results for use and review by a qualified clinician.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

该代码近三年的 510(k)(3 件)

数据窗口为最近三年。最新一件:2025-10-17。

510(k) 号批准日期申请人器械名称摘要
K2513552025-10-17Spectrawave, Inc.X1-FFRPDF
K2437692025-04-04Qfr Solutions BVQFR (3.0)PDF
K2321472024-04-09Pie Medical Imaging BVCAAS WorkstationPDF

其中 3 件的 Summary 已存档在本站,点 PDF 直接下载;其余给 FDA 官方链接。

FDA 官方分类页: QHA
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。